This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olsen, A. W.
Right arrow Articles by Andersen, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olsen, A. W.
Right arrow Articles by Andersen, P.

 Previous Article  |  Next Article 

Infection and Immunity, October 2004, p. 6148-6150, Vol. 72, No. 10
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.10.6148-6150.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Protective Effect of a Tuberculosis Subunit Vaccine Based on a Fusion of Antigen 85B and ESAT-6 in the Aerosol Guinea Pig Model

Anja W. Olsen,1 Ann Williams,2 Limei M. Okkels,1,{dagger} Graham Hatch,2 and Peter Andersen1*

Department of Infectious Disease Immunology, Statens Serum Institute, Copenhagen, Denmark,1 Research Division, Health Protection Agency, Porton Down, Salisbury, United Kingdom2

Received 24 March 2004/ Returned for modification 21 May 2004/ Accepted 13 July 2004

A fusion protein of antigen 85B (Ag85B) and ESAT-6 administered in cationic lipid vesicles conferred a highly significant level of protection against Mycobacterium tuberculosis in the guinea pig aerosol model of infection. The protection was manifested as delayed clinical illness and prolonged survival. Neither Ag85B nor ESAT-6 (independently or as a cocktail) induced significant protection in this model.

* Corresponding author. Mailing address: Department of Infectious Disease Immunology, Statens Serum Institute, Artillerivej 5, DK-2300 Copenhagen S, Denmark. Phone: 45 32 68 34 62. Fax: 45 32 68 30 35. E-mail: pa{at}ssi.dk

Editor: J. D. Clements

{dagger} Present address: Core Facility Protein Analysis, Max Planck Institute for Infection Biology, Berlin, Germany.

Infection and Immunity, October 2004, p. 6148-6150, Vol. 72, No. 10
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.10.6148-6150.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Vordermeier, H. M., Dean, G. S., Rosenkrands, I., Agger, E. M., Andersen, P., Kaveh, D. A., Hewinson, R. G., Hogarth, P. J. (2009). Adjuvants Induce Distinct Immunological Phenotypes in a Bovine Tuberculosis Vaccine Model. CVI 16: 1443-1448 [Abstract] [Full Text]  
  • Mir, F.-A., Kaufmann, S. H. E., Eddine, A. N. (2009). A Multicistronic DNA Vaccine Induces Significant Protection against Tuberculosis in Mice and Offers Flexibility in the Expressed Antigen Repertoire. CVI 16: 1467-1475 [Abstract] [Full Text]  
  • Wang, X., Barnes, P. F., Dobos-Elder, K. M., Townsend, J. C., Chung, Y.-t., Shams, H., Weis, S. E., Samten, B. (2009). ESAT-6 Inhibits Production of IFN-{gamma} by Mycobacterium tuberculosis-Responsive Human T Cells. J. Immunol. 182: 3668-3677 [Abstract] [Full Text]  
  • Ciabattini, A., Pettini, E., Andersen, P., Pozzi, G., Medaglini, D. (2008). Primary Activation of Antigen-Specific Naive CD4+ and CD8+ T Cells following Intranasal Vaccination with Recombinant Bacteria. Infect. Immun. 76: 5817-5825 [Abstract] [Full Text]  
  • Bastian, M., Braun, T., Bruns, H., Rollinghoff, M., Stenger, S. (2008). Mycobacterial Lipopeptides Elicit CD4+ CTLs in Mycobacterium tuberculosis-Infected Humans. J. Immunol. 180: 3436-3446 [Abstract] [Full Text]  
  • Dietrich, J., Billeskov, R., Doherty, T. M., Andersen, P. (2007). Synergistic Effect of Bacillus Calmette Guerin and a Tuberculosis Subunit Vaccine in Cationic Liposomes: Increased Immunogenicity and Protection. J. Immunol. 178: 3721-3730 [Abstract] [Full Text]  
  • Andersen, C. S., Dietrich, J., Agger, E. M., Lycke, N. Y., Lovgren, K., Andersen, P. (2007). The Combined CTA1-DD/ISCOMs Vector Is an Effective Intranasal Adjuvant for Boosting Prior Mycobacterium bovis BCG Immunity to Mycobacterium tuberculosis. Infect. Immun. 75: 408-416 [Abstract] [Full Text]  
  • Dietrich, J., Andersen, C., Rappuoli, R., Doherty, T. M., Jensen, C. G., Andersen, P. (2006). Mucosal Administration of Ag85B-ESAT-6 Protects against Infection with Mycobacterium tuberculosis and Boosts Prior Bacillus Calmette-Guerin Immunity. J. Immunol. 177: 6353-6360 [Abstract] [Full Text]  
  • Majlessi, L., Simsova, M., Jarvis, Z., Brodin, P., Rojas, M.-J., Bauche, C., Nouze, C., Ladant, D., Cole, S. T., Sebo, P., Leclerc, C. (2006). An Increase in Antimycobacterial Th1-Cell Responses by Prime-Boost Protocols of Immunization Does Not Enhance Protection against Tuberculosis. Infect. Immun. 74: 2128-2137 [Abstract] [Full Text]  
  • Tsenova, L., Harbacheuski, R., Moreira, A. L., Ellison, E., Dalemans, W., Alderson, M. R., Mathema, B., Reed, S. G., Skeiky, Y. A. W., Kaplan, G. (2006). Evaluation of the Mtb72F Polyprotein Vaccine in a Rabbit Model of Tuberculous Meningitis. Infect. Immun. 74: 2392-2401 [Abstract] [Full Text]  
  • Wozniak, T. M., Ryan, A. A., Triccas, J. A., Britton, W. J. (2006). Plasmid Interleukin-23 (IL-23), but Not Plasmid IL-27, Enhances the Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection. Infect. Immun. 74: 557-565 [Abstract] [Full Text]  
  • Doherty, T. M., Andersen, P. (2005). Vaccines for Tuberculosis: Novel Concepts and Recent Progress. Clin. Microbiol. Rev. 18: 687-702 [Abstract] [Full Text]  
  • Dietrich, J., Aagaard, C., Leah, R., Olsen, A. W., Stryhn, A., Doherty, T. M., Andersen, P. (2005). Exchanging ESAT6 with TB10.4 in an Ag85B Fusion Molecule-Based Tuberculosis Subunit Vaccine: Efficient Protection and ESAT6-Based Sensitive Monitoring of Vaccine Efficacy. J. Immunol. 174: 6332-6339 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»